 Coronary hemodynamic effects atrial natriuretic peptide humans Studies effects atrial natriuretic peptide coronary circulation conflicting results animals human subjects direct coronary hemodynamic actions atrial natriuretic peptide humans safety administration patients coronary artery disease incremental doses synthetic atrial natriuretic peptide nitroglycerin left coronary artery patients coronary artery disease agents dose-related increases total coronary sinus blood flow dose atrial natriuretic peptide patients micrograms mean coronary sinus blood flow ml/min coronary vascular resistance mm Hg/ml min mean arterial blood pressure heart rate dose atrial natriuretic peptide changes coronary sinus blood flow coronary vascular resistance atrial natriuretic peptide administration patients coronary artery disease cardiovascular disease maximal effects atrial natriuretic peptide similar nitroglycerin untoward effects atrial natriuretic peptide direct coronary vasodilator humans maximal dose effects similar nitroglycerin small group patients physiologic importance therapeutic potential atrial natriuretic peptide patients coronary artery disease merit investigation